Blood test guides Life-Saving treatment to stop Cancer's return
NCT ID NCT06914011
Summary
This study aims to see if a personalized treatment plan can prevent esophageal cancer from coming back after surgery. It will enroll 172 patients who have had their cancer surgically removed but still have tiny amounts of cancer DNA in their blood, putting them at high risk for recurrence. These patients will be randomly assigned to either receive a combination of chemotherapy and immunotherapy drugs or to be closely monitored without additional drug treatment, to see which approach better keeps the cancer away.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ESOPHAGEAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.